Go to the list of all blogs
published in Blogs
Jul 21, 2026
iShares Russell 2000 ETF (IWM) Delivers +20% in Q2 as Small Caps Lead the Market

iShares Russell 2000 ETF (IWM) Delivers +20% in Q2 as Small Caps Lead the Market

Key Takeaways

  • The iShares Russell 2000 ETF delivers diversified exposure to approximately 2,000 U.S. small-cap stocks across industrials, healthcare, financials, and information technology, with a competitive 0.19% expense ratio and roughly $83 billion in assets under management (AUM).
  • After surging more than 20% during the second quarter of 2026 — its strongest quarterly performance in years — IWM has entered a period of consolidation, moving roughly 1% lower over the past 30 days.
  • Small-cap stocks have broadly outperformed large-cap benchmarks year-to-date, driven by a combination of resilient economic growth, AI-driven demand filtering into smaller industrials and technology firms, and a Federal Reserve policy stance that has stabilized borrowing costs.
  • Approximately 30% of Russell 2000 debt carries floating interest rates, making the fund structurally more sensitive to Federal Reserve policy shifts than large-cap indexes.
  • Earnings growth for Russell 2000 constituents is projected near 19% for 2026, outpacing S&P 500 estimates and providing a fundamental underpinning for the small-cap rally.

Overview of the iShares Russell 2000 ETF (IWM)

The iShares Russell 2000 ETF, issued by BlackRock and launched in May 2000, seeks to track the investment results of the Russell 2000 Index — the most widely followed benchmark for U.S. small-capitalization equities. The index comprises approximately 2,000 of the smallest stocks within the broader Russell 3000 Index, representing roughly 7% of that index's total market capitalization.

IWM's portfolio spans roughly 2,000 holdings, with no single position exceeding 0.4% of the fund. Top holdings include Moog Inc, Cytokinetics, BrightSpring Health Services, UMB Financial, Viasat, JFrog, Krystal Biotech, Hut 8 Corp, and CareTrust REIT. Sector weights are led by industrials at approximately 19%, information technology near 18%, healthcare around 16%, and financials at roughly 16%, followed by consumer discretionary, energy, real estate, and materials. This balanced sector composition differentiates IWM from large-cap benchmarks that have grown increasingly concentrated in mega-cap technology stocks. When scanning for comparable names, I occasionally reference Tickeron’s AI tools to cross-check sector exposures.

The fund operates as a passive, market-cap-weighted vehicle with an expense ratio of 0.19%. Its deep liquidity and active options market make it a primary instrument for institutional investors executing small-cap allocation and hedging strategies.

The Small-Cap Landscape and Key Themes

Small-cap equities entered 2026 with significant tailwinds after years of relative underperformance versus large-cap peers. By late 2025, the valuation gap between the Russell 2000 and the S&P 500 had reached a multi-decade extreme, with small caps trading at approximately 18 times forward earnings versus 26 times for large caps. That discount, combined with a cooling inflation trajectory and three consecutive Federal Reserve rate cuts in late 2025, set the stage for a rotation into domestically oriented, interest-rate-sensitive companies.

Several structural themes now shape the small-cap landscape. Artificial intelligence (AI) investment has broadened beyond hyperscale cloud providers, creating demand for semiconductor supply-chain participants, data center infrastructure providers, and specialized software firms — many of which reside in the Russell 2000. In parallel, reshoring trends and domestic infrastructure spending have disproportionately benefited U.S.-focused small-cap industrials and manufacturers. Legislative changes, including the restoration of full R&D expensing and 100% bonus depreciation, have further improved cash flow for capital-intensive smaller firms.

However, risks remain pronounced. Roughly 30% of Russell 2000 constituent debt carries floating rates, compared to approximately 7% for the S&P 500. Interest expense now accounts for approximately 31% of EBITDA (earnings before interest, taxes, depreciation, and amortization) for Russell 2000 firms, a level that has more than doubled since 2020. Nearly 40% of Russell 2000 companies remain unprofitable. The June 2026 index reconstitution also halved the weight of AI infrastructure stocks within the benchmark, reducing a key performance driver from approximately 15% to 7%.

Recent Performance and Positioning

IWM delivered a standout second quarter, climbing approximately 20.4% from its April 1 closing level of $249.56 to $300.45 by June 30. That quarter represented the Russell 2000's strongest performance since the fourth quarter of 2020 and contributed to a year-to-date gain exceeding 19% through mid-July. For context, the S&P 500 advanced roughly 9-10% over the same period, underscoring the magnitude of the small-cap leadership rotation.

Over the most recent 30-day window, however, IWM has traded in a narrow range, edging roughly 1% lower as markets digested mixed signals. Oil prices spiked back above $80 per barrel amid renewed U.S.-Iran tensions, semiconductor stocks experienced a sharp pullback, and uncertainty surrounding the Federal Reserve's policy path under Chair Kevin Warsh kept risk appetite in check. The consolidation follows a powerful rally and reflects a market pausing to assess whether fundamental earnings growth can sustain small-cap valuations at current levels. One thing that stands out in the holdings is the performance of names like Moog Inc and Hut 8 Corp, which have each posted triple-digit gains over the past year.

The fund's top holdings reflect the breadth of the small-cap opportunity set. Moog Inc, a motion-control systems manufacturer, and Hut 8 Corp, a digital asset infrastructure company, have each posted triple-digit percentage gains over the past year, benefiting from industrial and crypto-related demand respectively. BrightSpring Health Services and Cytokinetics represent the healthcare segment, where clinical milestones and demographic trends continue to attract investor capital. The fund's granular composition — with no position exceeding 0.4% — means performance is driven by broad sector and macro trends rather than idiosyncratic single-stock moves.

Leveraging AI Tools in Small-Cap Research

Identifying opportunities across thousands of small-cap stocks can be resource-intensive, which is where Tickeron's AI Screener adds practical value. The platform applies artificial intelligence to scan equities and ETFs using a broad array of criteria, including technical indicators, fundamental metrics, volatility patterns, and AI-generated trading signals. Users can filter by sector, industry, market capitalization, and performance characteristics to surface securities that match specific investment criteria — whether seeking breakout candidates, momentum plays, or fundamentally sound names trading at attractive valuations. For investors navigating the expansive small-cap universe, the AI Screener offers an efficient way to narrow the field and identify actionable ideas aligned with evolving market conditions. I have found this approach helpful when building watchlists for names that fit the themes discussed above.

2026 Outlook and Factors to Watch

The trajectory of IWM through the remainder of 2026 will likely hinge on several interrelated factors. First among them is Federal Reserve policy: markets currently price a roughly 35-basis-point probability of tightening by year-end. Any rate increase would disproportionately pressure small caps given their higher floating-rate debt exposure. Conversely, if the Fed remains on hold and inflation continues to moderate, the rate environment could remain supportive for small-cap earnings.

Earnings execution represents the second critical variable. Russell 2000 constituents are projected to deliver approximately 19% year-over-year earnings growth for full-year 2026. If those estimates materialize — particularly in the industrials, financials, and healthcare segments that dominate the index — small caps could maintain their relative valuation advantage. At a forward price-to-earnings multiple near 17, the Russell 2000 continues to trade at a discount to the S&P 500's roughly 20 times earnings, suggesting room for further multiple expansion if earnings delivery remains on track. I'm watching earnings reports closely in the coming quarters to see how this plays out.

Geopolitical risks, including the trajectory of Middle East tensions and their impact on energy prices, add uncertainty to the inflation outlook. Sustained oil prices above $80 per barrel could complicate the Fed's policy calculus and disproportionately affect the transportation, manufacturing, and consumer-facing small-cap segments. Additionally, the post-reconstitution Russell 2000 — now carrying a reduced AI infrastructure weight — may see leadership rotate toward traditional cyclical sectors, regional banks, and biotech, altering the performance profile investors have grown accustomed to during the first half of 2026.

Capital flows into small-cap ETFs remain a critical signal. After years of investor capital concentrating in large-cap and thematic technology funds, the broadening of market participation in 2026 has driven renewed interest in small-cap strategies. Whether institutional and retail investors continue to allocate toward diversified small-cap vehicles like IWM — rather than narrower factor-based or active alternatives — will influence both fund flows and index-level momentum in the months ahead.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IWM

IWM's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for IWM turned positive on October 05, 2026. Looking at past instances where IWM's MACD turned positive, the stock continued to rise in 39 of 44 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IWM's RSI Indicator exited the oversold zone, 23 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 53 cases where IWM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

Following a +1.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where IWM advanced for three days, in 274 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

IWM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day moving average for IWM crossed bearishly below the 50-day moving average on September 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IWM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for IWM entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are Transocean Ltd (NYSE:RIG), Lumen Technologies (NYSE:LUMN), Abercrombie & Fitch Co (NYSE:ANF), Valaris Limited (NYSE:VAL), California Resources Corp (NYSE:CRC), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Scorpio Tankers (NYSE:STNG), Tanger (NYSE:SKT), Synaptics (NASDAQ:SYNA), Fastly (NASDAQ:FSLY).

Industry description

The investment seeks to track the investment results of the Russell 2000® Index, which measures the performance of the small-capitalization sector of the U.S. equity market. The underlying index is a float-adjusted capitalization-weighted index of equity securities issued by the approximately 1,933 smallest issuers in the Russell 3000 Index. The fund may use derivatives to gain or reduce exposure to the components of the underlying index or exposure to one or more market risk factors associated with such components.

Market Cap

The average market capitalization across the iShares Russell 2000 ETF (IWM) ETF is 2.27B. The market cap for tickers in the group ranges from 29.98M to 11.91B. TWST holds the highest valuation in this group at 11.91B. The lowest valued company is CNTX at 29.98M.

High and low price notable news

The average weekly price growth across all stocks in the iShares Russell 2000 ETF (IWM) ETF was 75%. For the same ETF, the average monthly price growth was 393%, and the average quarterly price growth was 430%. SES experienced the highest price growth at 48%, while LQDA experienced the biggest fall at -63%.

Volume

The average weekly volume growth across all stocks in the iShares Russell 2000 ETF (IWM) ETF was -10%. For the same stocks of the ETF, the average monthly volume growth was 15% and the average quarterly volume growth was -23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 56
Price Growth Rating: 56
SMR Rating: 71
Profit Risk Rating: 78
Seasonality Score: 26 (-100 ... +100)
View a ticker or compare two or three
IWM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category SmallBlend

Category
Small Blend
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.